BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1387881)

  • 1. Do analogues of gonadotrophin releasing hormone influence follicular fluid steroid levels, oocyte maturity and fertilization rates?
    Tavmergen E; Tavmergen EN; Capanoğlu R
    Hum Reprod; 1992 Apr; 7(4):479-82. PubMed ID: 1387881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chorionic gonadotrophin and steroid concentrations in follicular fluid: the relationship to oocyte maturity and fertilization rates in stimulated and natural in-vitro fertilization cycles.
    Enien WM; el Sahwy S; Harris CP; Seif MW; Elstein M
    Hum Reprod; 1995 Nov; 10(11):2840-4. PubMed ID: 8747029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine composition of follicular fluid comparing human chorionic gonadotrophin to a gonadotrophin-releasing hormone agonist for ovulation induction.
    Yding Andersen C; Westergaard LG; Figenschau Y; Bertheussen K; Forsdahl F
    Hum Reprod; 1993 Jun; 8(6):840-3. PubMed ID: 8345072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between prolactin, gonadotrophins and steroid hormones in serum and follicular fluid after stimulation with gonadotrophin-releasing hormone agonists and human menopausal gonadotrophin for an in-vitro fertilization programme.
    Kamel MA; Zabel G; Bernart W; Neulen J; Breckwoldt M
    Hum Reprod; 1994 Oct; 9(10):1803-6. PubMed ID: 7844206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of oestradiol values in IVF-ET under a combined GnRH analogue--desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies.
    Mettler L; Tavmergen EN
    Hum Reprod; 1989 Nov; 4(8 Suppl):59-64. PubMed ID: 2533218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. III. Proteoglycans.
    Franchimont P; Hazee-Hagelstein MT; Hazout A; Gysen P; Salat-Baroux J; Schatz B; Demerle F
    Biol Reprod; 1990 Aug; 43(2):183-90. PubMed ID: 2143088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).
    Garcia-Velasco JA; Isaza V; Vidal C; Landazábal A; Remohí J; Simón C; Pellicer A
    Hum Reprod; 2001 Dec; 16(12):2533-9. PubMed ID: 11726570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization.
    Firmin C; Antoine JM; Millot F; Alvarez S; Debray M; Tibi C; Cornet D; Salat-Baroux J; Laruelle P
    Hum Reprod; 1991 May; 6(5):653-8. PubMed ID: 1834692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
    Teissier MP; Chable H; Paulhac S; Aubard Y
    Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin.
    Humaidan P; Westergaard LG; Mikkelsen AL; Fukuda M; Yding Andersen C
    Fertil Steril; 2011 May; 95(6):2034-8. PubMed ID: 21377153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and testosterone concentrations in follicular fluid as criteria to discriminate between mature and immature oocytes.
    Costa LO; Mendes MC; Ferriani RA; Moura MD; Reis RM; Silva de Sá MF
    Braz J Med Biol Res; 2004 Nov; 37(11):1747-55. PubMed ID: 15517092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between follicular fluid steroid analysis and maturity and cytogenetic analysis of human oocytes that remained unfertilized after in vitro fertilization.
    De Sutter P; Dhont M; Vanluchene E; Vandekerckhove D
    Fertil Steril; 1991 May; 55(5):958-63. PubMed ID: 1827078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation of interleukin 1 and tumour necrosis factor to oestradiol, progesterone and testosterone levels in periovulatory follicular fluid of in-vitro fertilization patients.
    Barak V; Mordel N; Holzer H; Zajicek G; Treves AJ; Laufer N
    Hum Reprod; 1992 Apr; 7(4):462-4. PubMed ID: 1522186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles.
    Vuong TNL; Ho MT; Ha TQ; Jensen MB; Andersen CY; Humaidan P
    J Assist Reprod Genet; 2017 Apr; 34(4):471-478. PubMed ID: 28197932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human preovulatory follicular fluid: inhibin and free steroids related to optimal follicular maturation in ovarian stimulation regimes and possible function in ovulation.
    Andersen CY; Westergaard LG; Sinosich MJ; Byskov AG
    Hum Reprod; 1992 Jul; 7(6):765-9. PubMed ID: 1500472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ovarian granulosa cells and follicular fluid indices: the relationship to oocyte maturity and fertilization in vitro.
    Enien WM; Chantler E; Seif MW; Elstein M
    Hum Reprod; 1998 May; 13(5):1303-6. PubMed ID: 9647563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women.
    Hugues JN; Torresani T; Herve F; Martin-Pont B; Tamboise A; Santarelli J
    Fertil Steril; 1991 May; 55(5):945-51. PubMed ID: 1827076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the refractory period to gonadotropin therapy in IVF-ET cycles post longacting gonadotropin-releasing hormone (GNRH) analogue.
    Ashkenazi J; Goldman GA; Dicker D; Feldberg D; Shelef M; Goldman JA
    Eur J Obstet Gynecol Reprod Biol; 1991 Mar; 39(1):37-40. PubMed ID: 1827627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.